Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony F Shields

Showing results (81-90 of 186) with videos related to

Pageof 19
Sort By:
Journal of Clinical Pharmacology|April 21, 2016
Integrating Dynamic Positron Emission Tomography and Conventional Pharmacokinetic Studies to Delineate Plasma and Tumor Pharmacokinetics of FAU, a Prodrug Bioactivated by Thymidylate SynthaseJing Li, Seongho Kim, Anthony F Shields, et al.
Cancer Metastasis Reviews|April 20, 2021
Gastrointestinal stromal tumor: a review of current and emerging therapiesBayan Al-Share, Abdulrahman Alloghbi, Mohammed Najeeb Al Hallak, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 5, 2005
Biodistribution and radiation dosimetry estimates of 1-(2'-deoxy-2'-(18)F-Fluoro-1-beta-D-arabinofuranosyl)-5-bromouracil: PET imaging studies in dogsSridhar Nimmagadda, Thomas J Mangner, Haihao Sun, et al.
Investigational New Drugs|July 22, 2005
A phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancerBasil F El-Rayes, Mark M Zalupski, Anthony F Shields, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 19, 2013
Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2Jason A Sprowl, Giuliano Ciarimboli, Cynthia S Lancaster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Analysis and reproducibility of 3'-Deoxy-3'-[18F]fluorothymidine positron emission tomography imaging in patients with non-small cell lung cancerAnthony F Shields, Jawana M Lawhorn-Crews, David A Briston, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 2, 2005
A simplified analysis of [18F]3'-deoxy-3'-fluorothymidine metabolism and retentionAnthony F Shields, David A Briston, Samatha Chandupatla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2015
Critical Shortage of African American Medical Oncologists in the United StatesLauren M Hamel, Robert Chapman, Mary Malloy, et al.
The Oncologist|December 19, 2019
Molecular Analyses of Left- and Right-Sided Tumors in Adolescents and Young Adults with Colorectal CancerMohamed E Salem, Francesca Battaglin, Richard M Goldberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Phase II trial of intravenous CI-1042 in patients with metastatic colorectal cancerOday Hamid, Mary L Varterasian, Scott Wadler, et al.
Pageof 19

Showing results (81-90 of 186) with videos related to

Sort By:
Pageof 19
Journal of Clinical Pharmacology|April 21, 2016
Integrating Dynamic Positron Emission Tomography and Conventional Pharmacokinetic Studies to Delineate Plasma and Tumor Pharmacokinetics of FAU, a Prodrug Bioactivated by Thymidylate SynthaseJing Li, Seongho Kim, Anthony F Shields, et al.
Cancer Metastasis Reviews|April 20, 2021
Gastrointestinal stromal tumor: a review of current and emerging therapiesBayan Al-Share, Abdulrahman Alloghbi, Mohammed Najeeb Al Hallak, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 5, 2005
Biodistribution and radiation dosimetry estimates of 1-(2'-deoxy-2'-(18)F-Fluoro-1-beta-D-arabinofuranosyl)-5-bromouracil: PET imaging studies in dogsSridhar Nimmagadda, Thomas J Mangner, Haihao Sun, et al.
Investigational New Drugs|July 22, 2005
A phase II study of celecoxib, gemcitabine, and cisplatin in advanced pancreatic cancerBasil F El-Rayes, Mark M Zalupski, Anthony F Shields, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 19, 2013
Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2Jason A Sprowl, Giuliano Ciarimboli, Cynthia S Lancaster, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2008
Analysis and reproducibility of 3'-Deoxy-3'-[18F]fluorothymidine positron emission tomography imaging in patients with non-small cell lung cancerAnthony F Shields, Jawana M Lawhorn-Crews, David A Briston, et al.
European Journal of Nuclear Medicine and Molecular Imaging|July 2, 2005
A simplified analysis of [18F]3'-deoxy-3'-fluorothymidine metabolism and retentionAnthony F Shields, David A Briston, Samatha Chandupatla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 23, 2015
Critical Shortage of African American Medical Oncologists in the United StatesLauren M Hamel, Robert Chapman, Mary Malloy, et al.
The Oncologist|December 19, 2019
Molecular Analyses of Left- and Right-Sided Tumors in Adolescents and Young Adults with Colorectal CancerMohamed E Salem, Francesca Battaglin, Richard M Goldberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2003
Phase II trial of intravenous CI-1042 in patients with metastatic colorectal cancerOday Hamid, Mary L Varterasian, Scott Wadler, et al.
Pageof 19